Pacific GeneTech

Founded in 2009, Pacific GeneTech is dedicated to developing and commercializing innovative vaccines aimed at addressing high unmet needs in food safety and livestock animal health. Utilizing their proprietary "Aegis" technology platform, the company creates next-generation vaccines that offer broad-spectrum protection and can be administered orally or by injection. Their core mission is to enhance livestock health and food safety, thereby reducing the economic burden of livestock illness on producers. Pacific GeneTech targets the global animal vaccine market, which is projected to reach $20.6 billion by 2021.

Pacific GeneTech has garnered attention from notable investors and industry experts due to its groundbreaking work in vaccine development. The company's achievements include the successful development of several first-in-class or best-in-class vaccines, which have significantly impacted livestock health management. By focusing on both veterinary and potential human applications, Pacific GeneTech has established itself as a key player in the biotechnology sector, contributing to improved food safety and public health worldwide.